Accelerating Past Gutenberg and Google to the Cognitive Age
Personal Perspective: A future powered by connection between human minds and LLMs, promises a world in which our capacity for thought and innovation is unlocked.
Personal Perspective: A future powered by connection between human minds and LLMs, promises a world in which our capacity for thought and innovation is unlocked.
Amid expectations for a rise in M&A activity, market watchers are keeping their eyes on biopharma companies that are ripe for the taking.
Can active inference model consciousness? We offer three conditions implying that it can. The first condition is the simulation of a world or reality model,…
Memories are encoded by sparse populations of neurons but how such sparsity arises remains largely unknown. We found that a neuron’s eligibility to be recruited…
Combined market cap falls 2% year over year, with 16 of the largest public companies losing value and just 5 outperforming the S&P 500.
Pfizer has paused enrollment in a Phase III trial assessing its Duchenne muscular dystrophy (DMD) gene therapy candidate fordadistrogene movaparvovec after acknowledging the sudden death…
For decades, depression has been ascribed to chemical deficiencies in the brain. New evidence suggests inflammation may cause depression.
GEN’s updated A-List of top 10 best-selling prescription drugs, based on 2023 sales, has seven of last year’s 10 top-selling drugs registered year-over-year sales gains,…
Research successes are driving gene therapy for inherited deafness to the clinic, but commercialization efforts are needed to sustain momentum.
Carcinotech can generate hundreds of printed tumors from one biopsy, intensifying cancer drug screening and personalized medicine testing.
Deciphering the complex interplay between neuronal activity and mitochondrial function is pivotal in understanding brain aging, a multifaceted process marked by declines in synaptic function…